Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Stone

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Immunology|July 7, 2007
Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA)M V Talor, J H Stone, J Stebbing, et al.
Arthritis and Rheumatism|May 16, 2001
Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safetyJ H Stone, M L Uhlfelder, D B Hellmann, et al.
Rheumatic Diseases Clinics of North America|November 29, 2001
Vasculitis. A collection of pearls and mythsJ H Stone, L H Calabrese, G S Hoffman, et al.
Arthritis Care & Research|June 8, 2012
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumaticaS Unizony, L Arias-Urdaneta, E Miloslavsky, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|November 26, 2003
Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditionsJ H Stone, M Talor, J Stebbing, et al.
Annals of the Rheumatic Diseases|July 31, 2008
Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitisP A Merkel, D D Cuthbertson, B Hellmich, et al.
Clinical and Experimental Rheumatology|August 4, 2009
Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosisJ D Finkielman, P A Merkel, D Schroeder, et al.
Clinical and Experimental Immunology|January 12, 2017
Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitisJ M Clain, A M Hummel, J H Stone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2024
Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid-induced myopathyA He, B Koszegi, S Uzun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoidsE M Miloslavsky, U Specks, P A Merkel, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Immunology|July 7, 2007
Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA)M V Talor, J H Stone, J Stebbing, et al.
Arthritis and Rheumatism|May 16, 2001
Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safetyJ H Stone, M L Uhlfelder, D B Hellmann, et al.
Rheumatic Diseases Clinics of North America|November 29, 2001
Vasculitis. A collection of pearls and mythsJ H Stone, L H Calabrese, G S Hoffman, et al.
Arthritis Care & Research|June 8, 2012
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumaticaS Unizony, L Arias-Urdaneta, E Miloslavsky, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|November 26, 2003
Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditionsJ H Stone, M Talor, J Stebbing, et al.
Annals of the Rheumatic Diseases|July 31, 2008
Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitisP A Merkel, D D Cuthbertson, B Hellmich, et al.
Clinical and Experimental Rheumatology|August 4, 2009
Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosisJ D Finkielman, P A Merkel, D Schroeder, et al.
Clinical and Experimental Immunology|January 12, 2017
Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitisJ M Clain, A M Hummel, J H Stone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2024
Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid-induced myopathyA He, B Koszegi, S Uzun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoidsE M Miloslavsky, U Specks, P A Merkel, et al.
Pageof 7